RICHARD LIZAK: Open Payments
NPI 1972552370 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 20 payments from 13 companies in 2025. Trend: 2023 $254 · 2024 $278 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
Products named: REZDIFFRA, JARDIANCE, MOUNJARO, Cologuard Collection Kit, ELIQUIS, GVOKE HYPOPEN, ULTOMIRIS, REXULTI.
Industry payments across PA — which companies pay providers there.
